JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for autoimmune, ...

If you knew what really lived in your socks after even one day of wearing, you might just think twice about popping them on ...

Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at ...

Certain antibodies employ unusual tactics to keep germs from attaching to cells in our bodies. Their defensive strategies ...

An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important ...

The Bethlehem-based maker of at-home diagnostic tests said it submitted two separate applications to the FDA at the end of ...

New strains of Typhoid that can resist the strongest available antibiotics have emerged in South Asia, raising concerns over the potential spread of drug-resistant infections.

An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...